Both in Pharmaceuticals
Aktis Oncology vs Annexon
Over the past year AKTS returned −32.1% and ANNX returned −17.5%; their daily moves had a correlation of 0.24.
AKTS −32.1% ANNX −17.5%Growth of $1, one year, split-adjusted
| Metric | AKTS | ANNX |
|---|---|---|
| Price | $15.20 | $4.33 |
| Market cap | $845.4M | $820.9M |
| Today | +1.74% | +3.34% |
| 1 month | −14.9% | +7.4% |
| 6 months | −24.1% | −24.0% |
| Year to date | — | −13.7% |
| 1 year | — | +36.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | −713.5% | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $517.3M | $209.2M |
| Dividend yield | — | — |
| Volatility (60d) | 55.2% | 64.2% |
| Short % of float | 18.3% | 20.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).